Actively Recruiting
CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study
Led by Royal Marsden NHS Foundation Trust · Updated on 2025-06-11
36
Participants Needed
1
Research Sites
415 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A prospective imaging and translational tissue study in CNS lymphoma to enable further disease characterisation and the development of potential predictive and prognostic biomarkers.
CONDITIONS
Official Title
CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects capable of giving informed consent, or if appropriate, a legal representative can provide consent if the subject's capacity is limited due to CNS involvement
- A radiological or histological diagnosis of primary CNS lymphoma
- Have not received prior CNS directed therapy (prior use of steroids is permitted)
- Participants aged 18 years or older
You will not qualify if you...
- Lymphoma involvement outside of the central nervous system
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Royal Marsden NHS Foundation Trust, Downs Road
Sutton, United Kingdom, SM2 5PT
Actively Recruiting
Research Team
G
GI and Lymphoma Unit
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here